0000899243-22-007424.txt : 20220223 0000899243-22-007424.hdr.sgml : 20220223 20220223174523 ACCESSION NUMBER: 0000899243-22-007424 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220218 FILED AS OF DATE: 20220223 DATE AS OF CHANGE: 20220223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kaplan Brett CENTRAL INDEX KEY: 0001778763 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39696 FILM NUMBER: 22665273 MAIL ADDRESS: STREET 1: C/O PREVAIL THERAPEUTICS INC. STREET 2: 430 EAST 29TH STREET, SUITE 940 CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Compass Therapeutics, Inc. CENTRAL INDEX KEY: 0001738021 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 80 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 BUSINESS PHONE: 617-500-8099 MAIL ADDRESS: STREET 1: 80 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 FORMER COMPANY: FORMER CONFORMED NAME: Olivia Ventures, Inc. DATE OF NAME CHANGE: 20180419 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-18 0 0001738021 Compass Therapeutics, Inc. CMPX 0001778763 Kaplan Brett C/O COMPASS THERAPEUTICS, INC. 80 GUEST STREET, SUITE 601 BOSTON MA 02135 1 0 0 0 Stock Option (Right to Buy) 2.40 2022-02-18 4 A 0 30000 0.00 A 2032-02-17 Common Stock 30000 30000 D This option vests in substantially equal monthly installments over four years. /s/ Vered Bisker-Leib, attorney-in-fact 2022-02-23